JP2015164933A5 - - Google Patents

Download PDF

Info

Publication number
JP2015164933A5
JP2015164933A5 JP2015090380A JP2015090380A JP2015164933A5 JP 2015164933 A5 JP2015164933 A5 JP 2015164933A5 JP 2015090380 A JP2015090380 A JP 2015090380A JP 2015090380 A JP2015090380 A JP 2015090380A JP 2015164933 A5 JP2015164933 A5 JP 2015164933A5
Authority
JP
Japan
Prior art keywords
composition
dextran
dtpa
concentration
less
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015090380A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015164933A (ja
JP6040276B2 (ja
Filing date
Publication date
Priority claimed from US12/362,778 external-priority patent/US20100196272A1/en
Application filed filed Critical
Publication of JP2015164933A publication Critical patent/JP2015164933A/ja
Publication of JP2015164933A5 publication Critical patent/JP2015164933A5/ja
Application granted granted Critical
Publication of JP6040276B2 publication Critical patent/JP6040276B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015090380A 2009-01-30 2015-04-27 ジエチレントリアミン五酢酸(dtpa)−デキストランを放射標識するための組成物 Active JP6040276B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12/362,778 US20100196272A1 (en) 2009-01-30 2009-01-30 Compositions for radiolabeling diethylenetriaminepentaacetic acid (dtpa)-dextran
US12/362,778 2009-01-30

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2011547973A Division JP5743905B2 (ja) 2009-01-30 2010-01-28 ジエチレントリアミン五酢酸(dtpa)−デキストランを放射標識するための組成物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016217326A Division JP6509796B2 (ja) 2009-01-30 2016-11-07 ジエチレントリアミン五酢酸(dtpa)−デキストランを放射標識するための組成物

Publications (3)

Publication Number Publication Date
JP2015164933A JP2015164933A (ja) 2015-09-17
JP2015164933A5 true JP2015164933A5 (cg-RX-API-DMAC7.html) 2015-12-03
JP6040276B2 JP6040276B2 (ja) 2016-12-07

Family

ID=42395938

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2011547973A Active JP5743905B2 (ja) 2009-01-30 2010-01-28 ジエチレントリアミン五酢酸(dtpa)−デキストランを放射標識するための組成物
JP2015090380A Active JP6040276B2 (ja) 2009-01-30 2015-04-27 ジエチレントリアミン五酢酸(dtpa)−デキストランを放射標識するための組成物
JP2016217326A Active JP6509796B2 (ja) 2009-01-30 2016-11-07 ジエチレントリアミン五酢酸(dtpa)−デキストランを放射標識するための組成物
JP2019071387A Expired - Fee Related JP6833892B2 (ja) 2009-01-30 2019-04-03 ジエチレントリアミン五酢酸(dtpa)−デキストランを放射標識するための組成物
JP2021015866A Withdrawn JP2021088566A (ja) 2009-01-30 2021-02-03 ジエチレントリアミン五酢酸(dtpa)−デキストランを放射標識するための組成物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2011547973A Active JP5743905B2 (ja) 2009-01-30 2010-01-28 ジエチレントリアミン五酢酸(dtpa)−デキストランを放射標識するための組成物

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2016217326A Active JP6509796B2 (ja) 2009-01-30 2016-11-07 ジエチレントリアミン五酢酸(dtpa)−デキストランを放射標識するための組成物
JP2019071387A Expired - Fee Related JP6833892B2 (ja) 2009-01-30 2019-04-03 ジエチレントリアミン五酢酸(dtpa)−デキストランを放射標識するための組成物
JP2021015866A Withdrawn JP2021088566A (ja) 2009-01-30 2021-02-03 ジエチレントリアミン五酢酸(dtpa)−デキストランを放射標識するための組成物

Country Status (9)

Country Link
US (4) US20100196272A1 (cg-RX-API-DMAC7.html)
EP (2) EP2392012B1 (cg-RX-API-DMAC7.html)
JP (5) JP5743905B2 (cg-RX-API-DMAC7.html)
KR (2) KR101765717B1 (cg-RX-API-DMAC7.html)
CN (1) CN102301429A (cg-RX-API-DMAC7.html)
AU (1) AU2010208624B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI1007487A2 (cg-RX-API-DMAC7.html)
CA (1) CA2750230C (cg-RX-API-DMAC7.html)
WO (1) WO2010087959A1 (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100196272A1 (en) 2009-01-30 2010-08-05 Neoprobe Corporation Compositions for radiolabeling diethylenetriaminepentaacetic acid (dtpa)-dextran
JP6163698B2 (ja) * 2013-03-21 2017-07-19 国立大学法人 千葉大学 マクロファージマンノース受容体を認識する新規多糖金属錯体化合物、及び、その医薬組成物
US20150023876A1 (en) 2013-07-22 2015-01-22 Navidea Biopharmaceuticals, Inc. Compositions, methods and kits for diagnosing and treating cd206 expressing cell-related disorders
JP5924795B2 (ja) 2014-06-13 2016-05-25 テンボロン オイ 複合体
US10806803B2 (en) 2014-07-17 2020-10-20 Ohio State Innovation Foundation Compositions for targeting macrophages and other CD206 high expressing cells and methods of treating and diagnosis
WO2016011415A2 (en) * 2014-07-17 2016-01-21 Ohio State Innovation Foundation Compounds and compositions for targeting macrophages and other mannose-binding c-type lectin receptor high expressing cells and methods of treating and diagnosis using same
EP3218352B1 (en) * 2014-11-13 2020-08-05 Waters Technologies Corporation Method for liquid chromatography calibration for labeled n-glycans, method for preparing a dextran ladder calibrant and calibrant
GB201504064D0 (en) 2015-03-10 2015-04-22 Accretion Biotechnology Ltd Method and kits for preparing radionuclide complexes
CN106317237B (zh) * 2015-07-03 2019-07-19 华中科技大学 一种用于spect成像的当归多糖衍生物及其合成方法
CN106188226B (zh) * 2016-07-04 2019-12-24 江苏省原子医学研究所 一种用于淋巴结检查的大分子显像剂及其制备方法
FR3054445B1 (fr) * 2016-07-26 2019-07-05 Laboratoires Cyclopharma Synthese d'une composition d'agent radioactif
US10695450B2 (en) 2016-07-26 2020-06-30 Laboratoires Cyclopharma Synthesis of a radioactive agent composition
US11007272B1 (en) 2016-10-07 2021-05-18 Navidea Biopharmaceuticals, Inc. Compounds and methods for diagnosis and treatment of viral infections
JP6329302B2 (ja) * 2017-05-10 2018-05-23 国立大学法人千葉大学 マクロファージマンノース受容体を認識する新規多糖金属錯体化合物、及び、その医薬組成物
WO2020202831A1 (ja) * 2019-03-29 2020-10-08 国立研究開発法人量子科学技術研究開発機構 放射性医薬の製造方法及び放射性医薬
JP2023533405A (ja) 2020-07-08 2023-08-03 ナビディア、バイオファーマスーティカルズ、インコーポレイテッド 均一に定められた分子量のマンノシル化デキストランおよびその誘導体の合成
US12006339B2 (en) 2022-05-20 2024-06-11 Navidea Biopharmaceuticals, Inc. CD206 targeted drug delivery vehicles carrying novel bisphosphonate drug payloads via a degradable linker
JP2025535006A (ja) 2022-10-03 2025-10-22 ナビディア、バイオファーマスーティカルズ、インコーポレイテッド 炭水化物ポリマーに結合されたアミン終端リーシュへの糖部分のアミド結合

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1053508B (it) * 1970-07-06 1981-10-10 Searle & Co Procedimento per prepare composizioni marcate adatte a mettere in evidenza alterazioni della mucosa gastrointestinale prodotto ottenuto e relativo metodo di impiego
US4364920A (en) * 1975-04-30 1982-12-21 Medi-Physics, Inc. Stable diagnostic reagents
US4048296A (en) * 1975-05-27 1977-09-13 Mallinckrodt, Inc. Radiopharmaceutical scanning agents
JPS5569517A (en) * 1978-11-20 1980-05-26 Nippon Mejifuijitsukusu Kk Labelling preparation for labelling of erythrocytes with radio-active technetium
SE465907B (sv) 1984-11-01 1991-11-18 Nyegaard & Co As Diagnosticeringsmedel innehaallande en paramagnetisk metall
US5336762A (en) 1985-11-18 1994-08-09 Access Pharmaceuticals, Inc. Polychelating agents for image and spectral enhancement (and spectral shift)
US4822594A (en) 1987-01-27 1989-04-18 Gibby Wendell A Contrast enhancing agents for magnetic resonance images
CS263561B1 (en) 1987-09-18 1989-04-14 Kery Vladimir Process for preparing water soluble allylderivatives of oligo and polysaccharides
GB8801646D0 (en) * 1988-01-26 1988-02-24 Nycomed As Chemical compounds
US5328679A (en) * 1988-04-01 1994-07-12 Immunomedics, Inc. Methods for technetium/rhenium labeling of proteins
DD286598A5 (de) 1989-06-29 1991-01-31 Adw Der Ddr,Zi F. Mulekularbiologie,De Verfahren zur einfuehrung von primaeren aminogruppen in wasserloesliche polymere
EP0516873A1 (en) * 1991-06-06 1992-12-09 THE STATE of ISRAEL Atomic Energy Commission Soreq Nuclear Research Center A method and kit for protein labelling with 99 mTC
US5789578A (en) 1996-01-11 1998-08-04 Massey University Methods for the preparation of resins with ligands attached thereto through a linking group comprising sulfide, sulfoxide or sulfone functionality
US20010055563A1 (en) * 1999-09-09 2001-12-27 Rhomed Incorporated Post-labeling stabilization of radiolabeled proteins and peptides
US6066309A (en) * 1996-02-02 2000-05-23 Rhomed Incorporated Post-labeling stabilization of radiolabeled proteins and peptides
WO1997028181A2 (en) * 1996-02-02 1997-08-07 Rhomed Incorporated Post-labeling stabilization of radiolabeled proteins and peptides
AU5135698A (en) 1996-11-28 1998-06-22 Nihon Schering K.K. Contrast compound, contrast medium for mri, and method for mri
ES2228536T3 (es) 1999-05-14 2005-04-16 The Regents Of The University Of California Soporte macromolecular a base de dextrano para un farmaco y suministro de un agente de diagnosotico.
US6887462B2 (en) * 2001-04-09 2005-05-03 Chiron Corporation HSA-free formulations of interferon-beta
US7666979B2 (en) 2002-03-01 2010-02-23 Bracco International B.V. Methods for preparing multivalent constructs for therapeutic and diagnostic applications and methods of preparing the same
MXPA04011624A (es) * 2002-05-24 2005-03-07 Schering Corp Anticuerpo neutralizante humano anti-igfr.
CA2517939C (en) 2003-03-03 2015-11-24 Dyax Corp. Peptides that specifically bind hgf receptor (cmet) and uses thereof
DE602005001833T2 (de) * 2004-10-29 2008-04-17 Pharma Mar S.A., Sociedad Unipersonal Zusammensetzungen enthaltend Ecteinascidin und einen Disaccharide
TWI398272B (zh) * 2005-03-08 2013-06-11 Intervet Int Bv 化學定義的安定劑
US20090155351A1 (en) * 2005-10-04 2009-06-18 Alk-Abello A/S Solid Vaccine Formulation
AU2007234612B2 (en) * 2006-12-14 2013-06-27 Johnson & Johnson Regenerative Therapeutics, Llc Protein stabilization formulations
EA019345B1 (ru) * 2007-03-05 2014-03-31 Кадила Хелзкэр Лимитед Композиции, содержащие конъюгаты пэг-интерферон-альфа и рафинозу в качестве криопротектора
US20100196272A1 (en) 2009-01-30 2010-08-05 Neoprobe Corporation Compositions for radiolabeling diethylenetriaminepentaacetic acid (dtpa)-dextran
US20150023876A1 (en) 2013-07-22 2015-01-22 Navidea Biopharmaceuticals, Inc. Compositions, methods and kits for diagnosing and treating cd206 expressing cell-related disorders
EP3169336A4 (en) 2014-07-17 2018-04-04 Ohio State Innovation Foundation Compositions for targeting macrophages and other cd206 high expressing cells and methods of treating and diagnosis
WO2016011415A2 (en) 2014-07-17 2016-01-21 Ohio State Innovation Foundation Compounds and compositions for targeting macrophages and other mannose-binding c-type lectin receptor high expressing cells and methods of treating and diagnosis using same

Similar Documents

Publication Publication Date Title
JP2015164933A5 (cg-RX-API-DMAC7.html)
JP2017066148A5 (cg-RX-API-DMAC7.html)
JP6833892B2 (ja) ジエチレントリアミン五酢酸(dtpa)−デキストランを放射標識するための組成物
US9211341B2 (en) Method of manufacturing a pharmaceutical composition having chelating type complex micelles
JP2014510728A5 (cg-RX-API-DMAC7.html)
HRP20240167T1 (hr) Formulacije ljudskih anti-rankl protutijela i postupci njihove upotrebe
JP2015212268A5 (cg-RX-API-DMAC7.html)
JP2015134763A5 (cg-RX-API-DMAC7.html)
RU2015121771A (ru) Мультивалентная композиция на основе конъюгатов пневмококковый полисахарид-белок
HRP20212027T1 (hr) Formulacije polialkilen oksidne asparaginaze i postupci njihove priprave i uporabe
AR043863A1 (es) Composiciones que contienen piperacilina y tazobactam, utiles para inyeccioines
AR094374A1 (es) Composiciones y métodos para el tratamiento de trastornos metabólicos
HRP20230929T1 (hr) Stabilni pripravci semaglutida i njihova upotreba
JP2019038796A5 (cg-RX-API-DMAC7.html)
JP2020520368A5 (cg-RX-API-DMAC7.html)
JP2019521179A5 (cg-RX-API-DMAC7.html)
BR112015029468A8 (pt) sistemas de dosagem oralmente administráveis, método para suplementar a nutrição de ferro em um indivíduo humano e métodos para mitigar um ou mais efeitos adversos gastrointestinais de ferro não absorvido
HRP20200196T1 (hr) Fiziološki balansirane injektabilne formulacije fosnetupitanta
JP2019501226A5 (cg-RX-API-DMAC7.html)
JP5340964B2 (ja) 腫瘍細胞に対する殺傷効果を備えた修飾されたヒドロキシポリマーコンジュゲート
JP2018537514A5 (cg-RX-API-DMAC7.html)
FI3554474T3 (fi) Mikafungiinikoostumuksia
HRP20230989T1 (hr) Novi sastavi željeza i metode njihove izrade i upotrebe
EP2491951B1 (en) Block copolymer for intraperitoneal administration containing anti-cancer agent, micelle preparation, and cancer therapeutic agent comprising the micelle preparation as active ingredient
JP2019038797A5 (cg-RX-API-DMAC7.html)